Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2011-02-17 Transaction in Own Shar…
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Daily share buy-back notice - Appendix 3E 2 pages 75.3KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and references ASX rules related to share buy-backs. It provides detailed information about the number of shares bought back, prices paid, and compliance statements. The document is short (2640 characters) and focuses specifically on reporting daily share buy-back activity. This matches the description of a 'Transaction in Own Shares' filing, which reports company buyback activities. There is no indication that this is an announcement of a report or a certification, so it is not RPA or RNS. Therefore, the correct classification is POS (Transaction in Own Shares).
2011-02-17 English
Initial Director`s Interest Notice 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, including the date of appointment and securities held (notably nil). This is a report of personal share transactions or interests by a company director, which aligns with the definition of Director's Dealing filings. The document length is short and focused solely on director interests, with no financial results or other report content. Therefore, the correct classification is Director's Dealing (DIRS).
2011-02-16 English
Half Yearly Report and Accounts 57 pages 1.0MB
Interim / Quarterly Report Classification · 100% confidence The document is a detailed announcement of interim financial results for the six months ended 31 December 2010, including profit figures, sales revenue, operational updates, business development, outlook, and segment performance. It contains substantive financial data such as net profit after tax, sales revenue, earnings per share, cash flow, and dividend information. The document also discusses business segments, product approvals, and corporate developments. The presence of comprehensive financial data and analysis for a half-year period clearly identifies this as an Interim / Quarterly Report rather than a brief earnings release or a simple announcement. The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement of a report. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2011-02-15 English
Director Appointment/Resignation 1 page 35.7KB
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new director to the company's board. It provides details about the new director's background and the chairman's comments. There is no financial data, no report attached or referenced, and no mention of voting results or other regulatory filings. This fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2011-02-15 English
Appendix 3B 7 pages 52.8KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and references ASX rules and the Corporations Act, indicating it is a regulatory filing related to securities issuance. It details the issuance of ordinary shares under a Performance Rights Plan, including number of shares, terms, and quotation application. The document is a formal announcement of new securities issued and application for quotation on the ASX, not a financial report or earnings release. It is a standard new issue announcement form used in Australian securities regulation. Therefore, it fits the category of Capital/Financing Update (CAP) as it relates to new share issuance and capital structure changes.
2011-01-31 English
Form 484 Change to Company Details 6 pages 2.0MB
Regulatory Filings
2011-01-19 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.